Clinical genomics expands the link between erroneous cell division, primary microcephaly and intellectual disability.
null SaimaAmjad KhanSajid AliJiuhong JiangZhichao MiaoAtif KamilShahid Niaz KhanStefan T AroldPublished in: Neurogenetics (2024)
Primary microcephaly is a rare neurogenic and genetically heterogeneous disorder characterized by significant brain size reduction that results in numerous neurodevelopmental disorders (NDD) problems, including mild to severe intellectual disability (ID), global developmental delay (GDD), seizures and other congenital malformations. This disorder can arise from a mutation in genes involved in various biological pathways, including those within the brain. We characterized a recessive neurological disorder observed in nine young adults from five independent consanguineous Pakistani families. The disorder is characterized by microcephaly, ID, developmental delay (DD), early-onset epilepsy, recurrent infection, hearing loss, growth retardation, skeletal and limb defects. Through exome sequencing, we identified novel homozygous variants in five genes that were previously associated with brain diseases, namely CENPJ (NM_018451.5: c.1856A > G; p.Lys619Arg), STIL (NM_001048166.1: c.1235C > A; p.(Pro412Gln), CDK5RAP2 (NM_018249.6 c.3935 T > G; p.Leu1312Trp), RBBP8 (NM_203291.2 c.1843C > T; p.Gln615*) and CEP135 (NM_025009.5 c.1469A > G; p.Glu490Gly). These variants were validated by Sanger sequencing across all family members, and in silico structural analysis. Protein 3D homology modeling of wild-type and mutated proteins revealed substantial changes in the structure, suggesting a potential impact on function. Importantly, all identified genes play crucial roles in maintaining genomic integrity during cell division, with CENPJ, STIL, CDK5RAP2, and CEP135 being involved in centrosomal function. Collectively, our findings underscore the link between erroneous cell division, particularly centrosomal function, primary microcephaly and ID.
Keyphrases
- intellectual disability
- single cell
- autism spectrum disorder
- early onset
- photodynamic therapy
- young adults
- copy number
- zika virus
- wild type
- cell therapy
- resting state
- white matter
- mental health
- spinal cord injury
- late onset
- cerebral ischemia
- hearing loss
- stem cells
- functional connectivity
- multiple sclerosis
- gene expression
- mesenchymal stem cells
- risk assessment
- transcription factor
- cell proliferation
- brain injury
- binding protein
- molecular docking
- amino acid
- duchenne muscular dystrophy
- genome wide analysis
- genome wide identification